Alzheimer’s Disease

To evaluate if a new investigational drug is safe and effective in improving
symptoms of mild to moderate Alzheimer’s disease.

You or someone you know may be eligible if you:

♦ Are between 55 and 85 years of age
♦ Have been diagnosed with Alzheimer’s
disease
♦ Have a reliable support person or caregiver
who is willing to participate in study visits,
report on daily activities and oversee or
help you with taking ATH-1017

Name*
First Last
Address*
Street Address Address Line 2 City State ZIP Code
Primary Phone*
Primary Phone Type*
Secondary Phone
Secondary Phone Type
Email*
Age*
Gender*
* Required Field

Submission of this form does not guarantee your enrollment in any study, but it does let us know you have an interest in participating.
Email
This field is for validation purposes and should be left unchanged.